Home Biogen Idec wins Canadian approval for hemophilia drug Alprolix
 

Keywords :   


Biogen Idec wins Canadian approval for hemophilia drug Alprolix

2014-03-21 15:39:52| Biotech - Topix.net

Hemophilia B, a rare inherited disorder in which the ability of a person's blood to clot is impaired, affects some 4,000 people in the United States and roughly 25,000 worldwide.

Tags: drug approval canadian wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Still no sign of herd rebuilding
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
More »